Arrowhead Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, September 23, 2016 /EINPresswire.com/ -- The report provides comprehensive information on the therapeutics under development by Arrowhead Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Complete Report @ https://www.wiseguyreports.com/reports/649762-arrowhead-pharmaceuticals-inc-product-pipeline-review-2016

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Arrowhead Pharmaceuticals, Inc.
- The report provides overview of Arrowhead Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Arrowhead Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Arrowhead Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Get Sample Report @ https://www.wiseguyreports.com/sample-request/649762-arrowhead-pharmaceuticals-inc-product-pipeline-review-2016

Reasons to buy
- Evaluate Arrowhead Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Arrowhead Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Arrowhead Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Have any query @ https://www.wiseguyreports.com/enquiry/649762-arrowhead-pharmaceuticals-inc-product-pipeline-review-2016

Table of Content

Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Arrowhead Pharmaceuticals, Inc. - Pipeline Products Glance 12
Arrowhead Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Arrowhead Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Arrowhead Pharmaceuticals, Inc. - Drug Profiles 15
ARC-520 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ARC-521 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Adipotide 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ARC-AAT 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
BMTP-11 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ARC-HIF2 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
ARC-LPA 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ARCF-12 23
Product Description 23
Mechanism of Action 23
R&D Progress 23

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=649762

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here